Effect of liver specific oxysterol 7α-hydroxylase (CYP7B1) overexpression on the Western diet (WD)-induced metabolic dysfunction-associated steatotic liver disease (MASLD) progression was studied in mice. Among various hepatic genes impacted during MASLD development, CYP7B1 is consistently suppressed in multiple MASLD mouse models and in human MASLD cohorts. CYP7B1 enzyme suppression leads to accumulations of bioactive oxysterols such as (25R)26-hydroxycholesterol (26HC) and 25-hydroxycholesterol (25HC). We challenged liver specific CYP7B1 transgenic (CYP7B1(hep.tg)) overexpressing mice with ad libitum WD feeding. Unlike their WT counterparts, WD-fed CYP7B1(hep.tg) mice developed no significant hepatotoxicity as evidenced by liver histology, lipid quantifications, and serum biomarker analyses. Hepatic 26HC and 25HC levels were maintained at the basal levels. The comparative gene expression/lipidomic analyses between WT and CYP7B1(hep.tg) mice revealed that chronically accumulated 26HC initiates LXR/PPAR-mediated hepatic fatty acid uptake and lipogenesis which surpasses fatty acid metabolism and export; compromising metabolic functions. In addition, major pathways related to oxidative stress, inflammation, and immune system including retinol metabolism, arachidonic acid metabolism, and linoleic acid metabolism were significantly impacted in the WD-fed WT mice. All pathways were unaltered in CYP7B1(hep.tg) mice liver. Furthermore, the nucleus of WT mouse liver but not of CYP7B1(hep.tg) mouse liver accumulated 26HC and 25HC in response to WD. These data strongly suggested that these two oxysterols are specifically important in nuclear transcriptional regulation for the described cytotoxic pathways. In conclusion, this study represents a "proof-of-concept" that maintaining normal mitochondrial cholesterol metabolism with hepatic CYP7B1 expression prevents oxysterol-driven liver toxicity; thus attenuating MASLD progression.
Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression.
肝脏特异性转基因表达CYP7B1可减轻早期西方饮食诱发的MASLD进展
阅读:5
作者:Kakiyama Genta, Bai-Kamara Nanah, Rodriguez-Agudo Daniel, Takei Hajime, Minowa Kei, Fuchs Michael, Biddinger Sudha, Windle Jolene J, Subler Mark A, Murai Tsuyoshi, Suzuki Mitsuyoshi, Nittono Hiroshi, Sanyal Arun, Pandak William M
| 期刊: | Journal of Lipid Research | 影响因子: | 4.100 |
| 时间: | 2025 | 起止号: | 2025 Mar;66(3):100757 |
| doi: | 10.1016/j.jlr.2025.100757 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
